Interesting that these options may vest on sale of the sleep apnoea assets. Wonder what the thinking is behind that. Are they not considered core assets of the company?
Ann: Appendix 3B, page-4
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #